Skip to content

Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD

Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD. Indication of a Control Imaging ?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06173427
Acronym
Head-Trauma
Enrollment
180
Registered
2023-12-15
Start date
2019-11-01
Completion date
2023-12-31
Last updated
2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Trauma

Keywords

Head Trauma, Intracranial hemorrhage, Cerebral hemorrhagic lesions, Neurological monitoring, Brain scan

Brief summary

The non-neurosurgical management of post-traumatic cerebral hemorrhagic lesions is currently poorly codified. It consists of neurological monitoring for 24 to 48 hours, and the performance of an almost systematic brain scan. Anti-aggregation and anticoagulation treatments are stopped for 14 to 28 days and should be resumed according to the risk-benefit ratio and the advice of the patient's treating physicians and cardiologists. If the bleeding lesions do not progress, the patients are allowed to return home. If the lesions progress, the patients remain hospitalized for further monitoring, a new brain scan and neurosurgical advice. This study seeks to show that the performance of systematic brain imaging in the absence of clinical deterioration of patients admitted to the UHCD for post-traumatic intracranial hemorrhage could be avoided, and thus to administer an unnecessary dose of irradiation to the patients, and would also have a significant financial stake. Several recent studies have shown that there is no need to perform a follow-up brain scan in the absence of neurological deterioration, even in anticoagulated patients or those on antiplatelet drugs. Despite the growing number of articles, no recommendation or consensus has been proposed.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient (≥18 years old) * Admitted to Emergency department of the Strasbourg University Hospital during the year 2017 (from 01/01/2017 to 31/12/2017) * Patient having given his consent to the reuse of his data for the purpose of this research * Hospitalized at the University Hospital for monitoring of a post-traumatic intracranial hemorrhage

Exclusion criteria

* Patient having expressed opposition to participate in the study * Non-isolated cranial trauma (MVA, fall greater than 6 meters ..) * Subject under court protection * Subject under guardianship or curatorship

Design outcomes

Primary

MeasureTime frame
Retrospective description of clinical evolution of post-traumatic intracerebral hemorrhagesThrough study completion, an average of 4 months

Countries

France

Contacts

Primary ContactFlorent BAICRY, MD
florent.baicry@chru-strasbourg.fr33 3 88 12 86 82

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026